切换至 "中华医学电子期刊资源库"
高级检索
中华关节外科杂志(电子版)

中华关节外科杂志(电子版) ›› 2019, Vol. 13 ›› Issue (02) : 206 -212,250. doi: 10.3877/cma.j.issn.1674-134X.2019.02.013

所属专题： 文献；

综述

关节假体感染的预防研究进展
朱崇尊1, 杨闯1, 沈灏1,†()   
  1. 1. 200233　上海交通大学附属六人民医院骨科
  • 收稿日期:2018-04-01 出版日期:2019-04-01
  • 通信作者: 沈灏
  • 基金资助:
    国家自然科学基金(81472108，81772364)

Progress in prevention of prosthesis joint infection

Chongzun Zhu1, Chuang Yang1, Hao Shen1,†()   

  1. 1. Department of Orthopaedic Surgery, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai 200233, China
  • Received:2018-04-01 Published:2019-04-01
  • Corresponding author: Hao Shen
  • About author:
    Corresponding author: Shen Hao, Email:
全文 ( ) 下载PDF ( ) 导出引用
引用本文：

朱崇尊, 杨闯, 沈灏. 关节假体感染的预防研究进展[J]. 中华关节外科杂志(电子版), 2019, 13(02): 206-212,250.

Chongzun Zhu, Chuang Yang, Hao Shen. Progress in prevention of prosthesis joint infection[J]. Chinese Journal of Joint Surgery(Electronic Edition), 2019, 13(02): 206-212,250.

针对膝、髋关节严重关节畸形及功能障碍，关节置换是治疗膝、髋关节终末病变的最为有效、安全的治疗措施。然而这一显著提高患者生活质量的手段还有很多并发症，其中人工关节感染是人工关节置换术后最严重的并发症，一旦发生感染，会给患者带来巨大的身体负担和经济压力。而预防是应对关节感染最为经济有效的措施。所以了解人工关节置换术中导致感染的危险因素，及时采取预防措施十分必要。本文针对这些问题作一综述。

关键词: 人工关节, 感染, 预防

For knee and hip joint deformity and dysfunction, joint replacement is the most effective and safe treatment for knee and hip terminal diseases. However this improvement of life quality of patient means there are many complications, including artificial joint infection which is the most serious complication after artificial joint replacement. In case of infection, it can bring huge body burden to patients and economic pressure. Prevention is the most cost-effective measure of joint infection. Therefore, it is necessary to understand the risk factors of infection in artificial joint replacement and take preventive measures in time. This article reviewed these problems.

Key words: Joint prosthesis, Infection, Prevention
[1]
Bozic KJ, Ward DT, Lau EC, et al. Risk factors for periprosthetic joint infection following primary total hip arthroplasty: a case control study[J]. J Arthroplasty, 2014, 29(1): 154-156.
[2]
Kurtz S, Ong K, Lau E, et al. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030[J]. J Bone Joint Surg Am, 2007, 89(4): 780-785.
[3]
Havelin LI, Fenstad AM, Salomonsson RA, et al. The Nordic arthroplasty register association a unique collaboration between 3 national hip arthroplasty registries with 280 201 THRs[J]. Acta Orthop, 2009, 80(4): 393-401.
[4]
B A. D H, A H. Antibiotic prophylaxis for wound infections in total joint arthroplasty：a systematic review[J]. J Bone Joint Surg, 2008, 90(7): 915-919.
[5]
陈志，周宗科．髋膝关节置换术后假体周围感染的诊治进展[J]．实用骨科杂志，2017，23(3):247-251.
[6]
Eka A, Chen AF. Patient-related medical risk factors for periprosthetic joint infection of the hip and knee[J]. Ann Transl Med, 2015, 3(16): 233-234.
[7]
Aggarwal VK, Bakhshi H, Ecker NU, et al. Organism profile in periprosthetic joint infection: pathogens differ at two arthroplasty infection referral centers in Europe and in the United States[J]. J Knee Surg, 2014, 27(5): 399-405.
[8]
Jaberi FM, Parvizi J, Haytmanek C, et al. Procrastination of wound drainage and malnutrition affect the outcome of joint arthroplasty[J]. Clin Orthop Relat Res, 2008, 466(6): 1368-1371.
[9]
Cross MB, Yi PH, Thomas CF, et al. Evaluation of malnutrition in orthopaedic surgery[J]. J Am Acad Orthop Surg, 2014, 22(3): 193-199.
[10]
Guo JJ, Yang H, Qian H, et al. The effects of different nutritional measurements on delayed wound healing after hip fracture in the elderly[J]．J Surg Res, 2010, 159(1): 503-508.
[11]
Potter GD, Rao N, Mabry TM. Prevention of periprosthetic joint infection[J]. A Bone Joint Surg, 2015, 3(2): 72-81.
[12]
Greene KA, Wilde AH, Stulberg BN. Preoperative nutritional status of total joint patients：Relationship to postoperative wound complications[J]. J Arthroplasty, 1991, 6(4): 321-325.
[13]
Pitto RP. CORR insights (R): is potential malnutrition associated with septic failure and acute infection after revision total joint arthroplasty？[J]. Clin Orthop Relat Res, 2015, 473(1): 183-184.
[14]
Zmistowski B, Tetreault MW, Alijanipour P, et al. Recurrent periprosthetic joint infection：persistent or new infection？[J]. J Arthroplasty, 2013, 28(9): 1486-1489.
[15]
Nawabi DH, Chin KF, Keen RW, et al. Vitamin D deficiency in patients with osteoarthritis undergoing total hip replacement: a cause for concern？[J]. J Bone Joint Surg Br, 2010, 92B(4): 496-499.
[16]
Maier GS, Horas K, Seeger JB, et al. Is there an association between periprosthetic joint infection and low vitamin D levels？[J]. Int Orthop, 2014, 38(7): 1499-1504.
[17]
Stryker LS, Abdel MP, Morrey ME, et al. Elevated postoperative blood glucose and preoperative hemoglobin a1C are associated with increased wound complications following total joint arthroplasty[J]. J Bone Joint Surg Am, 2013, 95A(9): 808-814.
[18]
Capozzi JD, Lepkowsky ER, Callari MM, et al. The prevalence of diabetes mellitus and routine hemoglobin a1c screening in elective total joint arthroplasty patients[J]. J Arthroplasty, 2017, 32(1): 304-308.
[19]
Marchant J, Viens NA, Cook CA, et al. The impact of glycemic control and diabetes mellitus on perioperative outcomes after total joint arthroplasty[J]. J Bone Joint Surg Am, 2009, 91A(7): 1621-1629.
[20]
Dronge AS, Perkal MF, Kancir S, et al. Long-term glycemic control and postoperative infectious complications[J]. Arch Surg, 2006, 141(4): 375-380.
[21]
Chrastil J, Anderson MB, Stevens V, et al. Is hemoglobin a1c or perioperative hyperglycemia predictive of periprosthetic joint infection or death following primary total joint arthroplasty？[J]. J Arthroplasty, 2015, 30(7): 1197-1202.
[22]
Wang Y, Simpson JA, Wluka AE, et al. Relationship between body adiposity measures and risk of primary knee and hip replacement for osteoarthritis：a prospective cohort study[J]. Arthritis Res Ther, 2009, 11(2): 1-10.
[23]
Triantafyllopoulos GK, Soranoglou VG, Sculco TP, et al. Rate and risk factors for periprosthetic joint infection among 36, 494 primary total hip arthroplasties[J]. J Arthroplasty, 2018, 33(4): 1166-1170.
[24]
Tayton ER, Frampton C, Hooper GJ, et al. The impact of patient and surgical factors on the rate of infection after primary total knee arthroplasty: an analysis of 64 566 joints from the New Zealand Joint Registry[J]. Bone Joint J, 2016, 98B(3): 334-340.
[25]
Chirca I, Marculescu C. Prevention of infection in orthopedic prosthetic surgery[J]. Infect Dis Clin North Am, 2017, 31(2): 253-263.
[26]
Schnaser EA, Browne JA, Padgett DE, et al. Perioperative complications in patients with inflammatory arthropathy undergoing total knee arthroplasty[J]. J Arthroplasty, 2015, 30(10): 76-80.
[27]
Ravi B, Croxford R, Hollands S, et al. Increased risk of complications following total joint arthroplasty in patients with rheumatoid arthritis[J]. Analyst, 2014, 66(2): 254-263.
[28]
Tada M, Inui K, Sugioka Y, et al. Delayed wound healing and postoperative surgical site infections in patients with rheumatoid arthritis treated with or without biological disease-modifying antirheumatic drugs[J]. Clin Rheumatol, 2016, 35(6): 1475-1481.
[29]
Ding T, Ledingham J, Luqmani R, et al. BSR and BHPR rheumatoid arthritis guidelines on safety of anti-TNF therapies[J]. Rheumatology, 2010, 49(11): 2217-2219.
[30]
Marculescu CE, Mabry T, Berbari EF. Prevention of surgical site infections in joint replacement surgery[J]. Surg Infect (Larchmt), 2016, 17(2): 152-157.
[31]
Kunutsor SK, Whitehouse MR, Blom AW, et al. Patient-related risk factors for periprosthetic joint infection after total joint arthroplasty: a systematic review and meta-analysis[J/OL]. PLoS One, 2016, 11(3): e0150866. doi：10.1371/journal.pone.0150866.
[32]
Bozic KJ, Lau E, Kurtz S, et al. Patient-related risk factors for postoperative mortality and periprosthetic joint infection in medicare patients undergoing TKA[J]. Clin Orthop Relat Res, 2012, 470(1): 130-137.
[33]
Leonard BE. The immune system, depression and the action of antidepressants[J]. Prog Neuropsychopharmacol Biol Psychiatry, 2001, 25(4): 767-780.
[34]
Babayan RK. Wound healing and infection in surgery: the pathophysiological impact of smoking, smoking cessation, and nicotine replacement therapy：a systematic review[J]. J Urol, 2012, 188(6): 2243-2244.
[35]
Teng SS, Yi CQ, Krettek C, et al. Smoking and risk of prosthesis-related complications after total hip arthroplasty: a meta-analysis of cohort studies[J/OL]. PLoS One, 2015, 10(4): e0125294. doi: 10.1371/journal.pone.0125294.
[36]
Ban KA, Minei JP, Laronga CA, et al. Executive summary of the American College of Surgeons and Surgical Infection Society: surgical site infection guidelines, 2016 update[J]. Surg Infect (Larchmt), 2017, 18(4, SI): 379-382.
[37]
Bradley KA, Rubinsky AD, Sun HL, et al. Alcohol screening and risk of postoperative complications in male VA patients undergoing major non-cardiac surgery[J]. J Gen Intern Med, 2011, 26(2): 162-169.
[38]
Tϕnnesen H, Nielsen PR, Lauritzen JB, et al. Smoking and alcohol intervention before surgery: evidence for best practice[J]. Br J Anaesth, 2009, 102(3): 297-306.
[39]
Rezapoor M, Parvizi J. Prevention of periprosthetic joint infection[J]. J Arthroplasty, 2015, 30(6): 902-907.
[40]
George J, Klika AK, Higuera CA. Use of chlorhexidine preparations in total joint arthroplasty[J]. J Bone Jt Infect, 2017, 2(1): 15-22.
[41]
Colling K, Statz C, Glover J, et al. Pre-operative antiseptic shower and bath policy decreases the rate of S．aureus and methicillin-resistant S．aureus surgical site infections in patients undergoing joint arthroplasty[J]. Surg Infect (Larchmt), 2015, 16(2): 124-132.
[42]
Climo MW, Sepkowitz KA, Zuccotti G, et al. The effect of daily bathing with chlorhexidine on the acquisition of methicillin-resistant staphylococcus aureus, vancomycin-resistant enterococcus, and healthcare-associated bloodstream infections: results of a quasi-experimental multicenter trial[J]. Crit Care Med, 2009, 37(6): 1858-1865.
[43]
Potter GD, Rao N, Mabry TM. Prevention of periprosthetic joint infection[J]. A Bone Joint Surg, 2017, 99-B(4 Supple B): 3-10.
[44]
Morrison TN, Chen AF, Taneja MA, et al. Single vs repeat surgical skin preparations for reducing surgical site infection after total joint arthroplasty: a prospective, randomized, double-blinded study[J]. J Arthroplasty, 2016, 31(6): 1289-1294.
[45]
Shahi A, Eajazi A. Prevention of periprosthetic joint infection: pre-and intraoperative considerations[J]. J Bone Joint Surg Br, 2015, 38(4): 219-221.
[46]
Broekman ML, Van Beijnum J, Peul WC. Neurosurgery and shaving: what’s the evidence? A review[J]. J Neurosurg, 2011, 115(4): 670-678.
[47]
Price CS, Williams A, Philips G, et al. Staphylococcus aureus nasal colonization in preoperative orthopaedic outpatients[J]. Clin Orthop Relat Res, 2008, 466(11): 2842-2847.
[48]
Bode LG, Kluytmans JA, Wertheim HF, et al. Preventing surgical-site infections in nasal carriers of staphylococcus aureus[J]. N Engl J Med, 2010, 362(1): 9-17.
[49]
Grothe C, Taminato M, Belasco A, et al. Screening and treatment for staphylococcus aureus in patients undergoing hemodialysis: a systematic review and meta-analysis[J]. BMC Nephrol, 2014, 15(1): 202-205.
[50]
Botelho-Nevers E, Gagnaire J, Verhoeven PO, et al. Decolonization of staphylococcus aureus carriage[J]. Med Mal Infect, 2017, 47(5): 305-310.
[51]
Torres EG, Lindmair-Snell JM, Langan JW, et al. Is preoperative nasal povidone-iodine as efficient and cost-effective as standard methicillin-resistant staphylococcus aureus screening protocol in total joint arthroplasty？[J]. J Arthroplasty, 2016, 31(1): 215-218.
[52]
Parvizi J, Alijanipour P, Barberi EF, et al. Novel developments in the prevention, diagnosis, and treatment of periprosthetic joint infections[J]. J Am Acad Orthop Surg, 2015, 23(Suppl): S32-S43.
[53]
Yang L, Zhou H, Cheng P, et al.A novel bivalent fusion vaccine induces broad immunoprotection against staphylococcus aureus infection in different murine models[J]. Clin Immunol, 2018, 188: 85-93.
[54]
Berbari EF, Osmon DR, Lahr B, et al. The Mayo prosthetic joint infection risk score: implication for surgical site infection reporting and risk stratification[J]. Infect Cotrol Hosp Epidemiol, 2012, 33(8): 774-781.
[55]
J M, K WS, N MR, et al. Current evidence for the use of laminar flow in reducing infection rates in total joint arthroplasty[J]. Open Orthop J, 2015, 9(1): 495-498.
[56]
G P. AC B, C B. Influence of laminar airflow on prosthetic joint infections：a systematic review[J]. J Hosp Infect, 2012, 81(2): 73-78.
[57]
Panaahi P, Casper DS, Parvizi J, et al. Operating room traffic is a major concern during total joint arthroplasty[J]. Clin Orthop Relat Res, 2013, 471(1): 343-344.
[58]
Bedard M, Pelletier-Roy R, Angers-Goulet MA, et al. Traffic in the operating room during joint replacement is a multidisciplinary problem[J]. Can J Surg, 2015, 58(4): 232-236.
[59]
Guo YP, Wong PM, Li Y, et al. Is double-gloving really protective? A comparison between the glove perforation rate among perioperative nurses with single and double gloves during surgery[J]. Am J Surg, 2012, 204(2): 210-215.
[60]
Makama JG, Okeme IM, Makamae J, et al. Glove perforation rate in surgery: a randomized, controlled study to evaluate the efficacy of double dloving[J]. Surgl Infect, 2016, 17(4):420-436.
[61]
Heller S, Rezapoor M, Parvizi J. Minimising. the risk of infection: a peri-operative checklist[J]. Bone Joint J, 2016, 98B(1, A): 18-22.
[62]
Shohat N, Parvizi J. Prevention of periprosthetic joint infection: examining the recent guidelines[J]. J Arthroplasty, 2017, 32(7): 2040-2046.
[63]
Albuhairan B, Hind D, Hutchinson A. Antibiotic prophylaxis for wound infections in total joint arthroplasty – a systematic review[J]. J Bone Joint Surg Br, 2008, 90B(7): 915-919.
[64]
Soriano A. CORR insights (R): vancomycin prophylaxis for total joint arthroplasty: incorrectly dosed and has a higher rate of periprosthetic infection than cefazolin[J]. Clin Orthop Relat Res, 2017, 475(7): 1775-1778.
[65]
Bratzler DW, Dellinger EP, Olsen KM, et al. Clinical practice guidelines for antimicrobial prophylaxis in surgery[J]. Surg Infect (Larchmt), 2013, 14(1): 73-156.
[66]
Havelin LI, Engesaeter LB, Espehaug B, et al. The Norwegian Arthroplasty Register: 11 years and 73, 000 arthroplasties[J]. Acta Orthop Scand, 2000, 71(4): 337-353.
[67]
Wang J, Zhu C, Cheng T, et al. A systematic review and meta-analysis of antibiotic-impregnated bone cement use in primary total hip or knee arthroplasty[J/OL]. PLoS One, 2013, 8(12): e82745. doi：10.1371/journal.pone.0082745.
[68]
Wang H, Qiu GX, Lin J, et al. Antibiotic bone cement cannot reduce deep infection after primary total knee arthroplasty[J]. Orthopedics, 2015, 38(6): e462-e466.
[69]
Miola M, Bistolfi A, Valsania MC, et al. Antibiotic-loaded acrylic bone cements：an in vitro study on the release mechanism and its efficacy[J]. Mater Sci Eng C Mater Biol Appl, 2013, 33(5): 302-305.
[70]
Jiranek WA, Hanssen AD, Greenwald AS. Antibiotic-loaded bone cement for infection prophylaxis in total joint replacement[J]. J Bone Joint Surg Am, 2006, 88(11): 2487-2500.
[71]
Van DH, Neut D, Schenk W, et al. Gentamicin release from polymethylmethacrylate bone cements and Staphylococcus aureus biofilm formation[J]. Acta Orthop Scand, 2000, 71(6): 625-629.
[72]
Kendall RW, Duncan CP, Smith JA, et al. Persistence of bacteria on antibiotic loaded acrylic depots.A reason for caution[J]．Clin Orthop Relat Res, 1996, 329(329): 273-280.
[73]
Parvizi J, Gehrke T, Chen AF. Proceedings of the international consensus on periprosthetic joint infection[J]. Bone Joint J, 2013, 95-b(11): 1450-1452.
[74]
Catelas I, Wimmer MA, Utzschneider S. Polyethylene and metal wear particles: characteristics and biological effects[J]. Semin Immunopathol, 2011, 33(3): 257-271.
[75]
王寿宇，阴宝盛，张卫国．关节置换术后深部感染的预防[J/CD]．中华临床医师杂志(电子版)，2012，17)(17):5013-5015.
[76]
Cloutier M, Mantovani D, Rosei F. Antibacterial coatings: challenges, perspectives, and opportunities[J]. Trends Biotechnol, 2015, 33(11): 637-652.
[77]
Wang J, Li J, Guo G, et al. Silver-nanoparticles-modified biomaterial surface resistant to staphylococcus: new insight into the antimicrobial action of silver[J]. Scientific reports, 2016, 6: 326-399.
[78]
Guo G, Zhou H, Wang Q, et al. Nano-layered magnesium fluoride reservoirs on biomaterial surfaces strengthen polymorphonuclear leukocyte resistance to bacterial pathogens[J]. Nanoscale, 2017, 9(2): 875-892.
[79]
Zhu Y, Zhang F, Chen W, et al. Risk factors for periprosthetic joint infection after total joint arthroplasty: a systematic review and meta-analysis[J]. J Hosp Infect, 2015, 89(2): 82-89.
[80]
Kapadia BH, Pivec R, Johnson AJ, et al. Infection prevention methodologies for lower extremity total joint arthroplasty[J]. Expert Rev Med Devices, 2013, 10(2): 215-224.
[81]
Hopper GP, Deakin AH, Crane EO, et al. Enhancing patient recovery following lower limb arthroplasty with a modern wound dressing: a prospective, comparative audit[J]. J Wound Care, 2012, 21(4): 200-203.
[82]
Grosso MJ, Berg A, Larussa S, et al. Silver-impregnated occlusive dressing reduces rates of acute periprosthetic joint infection after total joint arthroplasty[J]. J Arthroplasty, 2017, 32(3): 929-932.
[83]
Gillespie BM, Rickard CM, Thalib L, et al. Use of negative-pressure wound dressings to prevent surgical site complications after primary hip arthroplasty: a pilot RCT[J]. Surg Innov, 2015, 22(5): 488-495.
[84]
Mortazavi S, Hansen P, Zmistowski BA, et al. Hematoma following primary total hip arthroplasty: a grave complication[J]. J Arthroplasty, 2013, 28(3): 498-503.
[85]
de Dios-Pérez MS, Cordero-Ampuero J. Reply to: risk factors for infection in total knee arthroplasty, including previously unreported intraoperative fracture and deep venous thrombosis[J]. Rev Esp Cir Ortop Traumatol, 2016, 60(4):268-269.
[86]
Schousboe JT, Brown GA. Cost-effectiveness of low-molecular-weight heparin compared with aspirin for prophylaxis against venous thromboembolism after total joint arthroplasty[J]. J Bone Joint Surg Am, 2013, 95(14): 1256-1264.
[87]
Huang R, Buckley PS, Scott B, et al. Administration of aspirin as a prophylaxis agent against venous thromboembolism results in lower incidence of periprosthetic joint infection[J]. J Arthroplasty, 2015, 30(9, S): 39-41.
[88]
Jenny JY. Infections associated with dental procedures in total hip arthroplasty[J]. J Bone Joint Surg Br, 2000, 82(2):56-59.
[1] 林文, 王雨萱, 许嘉悦, 王矜群, 王睿娜, 何董源, 樊沛. 人工关节置换登记系统的研究进展[J]. 中华关节外科杂志(电子版), 2023, 17(06): 834-841.
[2] 李培杰, 乔永杰, 张浩强, 曾健康, 谭飞, 李嘉欢, 王静, 周胜虎. 细菌培养阴性的假体周围感染诊治的最新进展[J]. 中华关节外科杂志(电子版), 2023, 17(06): 827-833.
[3] 涂家金, 廖武强, 刘金晶, 涂志鹏, 毛远桂. 严重烧伤患者鲍曼不动杆菌血流感染的危险因素及预后分析[J]. 中华损伤与修复杂志(电子版), 2023, 18(06): 491-497.
[4] 廖锵云, 王震, 林洁玉, 廖夏, 邓锦华, 李杰峰, 邓建维, 李明, 荣新洲. 虎门地区创伤弧菌感染的临床观察[J]. 中华损伤与修复杂志(电子版), 2023, 18(05): 394-398.
[5] 杨瑞洲, 李国栋, 吴向阳. 腹股沟疝术后感染的治疗方法探讨[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(06): 715-719.
[6] 徐金林, 陈征. 抗菌药物临床应用监测对腹股沟疝修补术预防用药及感染的影响[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(06): 720-723.
[7] 李静如, 王江玲, 吴向阳. 简易负压引流在腹股沟疝术后浅部感染中的疗效分析[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(06): 745-749.
[8] 李秉林, 吕少诚, 潘飞, 姜涛, 樊华, 寇建涛, 贺强, 郎韧. 供肝灌注液病原菌与肝移植术后早期感染的相关性分析[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 656-660.
[9] 赵立力, 王魁向, 张小冲, 李志远. 血沉与C-反应蛋白比值在假体周围感染中的诊断价值分析[J]. 中华老年骨科与康复电子杂志, 2023, 09(06): 351-355.
[10] 卓少宏, 林秀玲, 周翠梅, 熊卫莲, 马兴灶. CD64指数、SAA/CRP、PCT联合检测在小儿消化道感染性疾病鉴别诊断中的应用[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 505-509.
[11] 李静静, 翟蕾, 赵海平, 郑波. 多囊肾合并囊肿的多重耐药菌感染一例并文献复习[J]. 中华临床医师杂志(电子版), 2023, 17(08): 920-923.
[12] 李达, 张大涯, 陈润祥, 张晓冬, 黄士美, 陈晨, 曾凡, 陈世锔, 白飞虎. 海南省东方市幽门螺杆菌感染现状的调查与相关危险因素分析[J]. 中华临床医师杂志(电子版), 2023, 17(08): 858-864.
[13] 卓徐鹏, 刘颖, 任菁菁. 感染性疾病与老年人低蛋白血症的相关性研究进展[J]. 中华临床医师杂志(电子版), 2023, 17(08): 896-899.
[14] 李琪, 黄钟莹, 袁平, 关振鹏. 基于某三级医院的ICU多重耐药菌医院感染影响因素的分析[J]. 中华临床医师杂志(电子版), 2023, 17(07): 777-782.
[15] 杨艳丽, 陈昱, 赵若辰, 杜伟, 马海娟, 许珂, 张莉芸. 系统性红斑狼疮合并血流感染的危险因素及细菌学分析[J]. 中华临床医师杂志(电子版), 2023, 17(06): 694-699.
阅读次数
全文


摘要

版权所有 中华医学会 中华医学电子音像出版社有限责任公司  京ICP备14006079号-1  网络出版服务许可证：(署)网出证(京)字第075号